Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients

被引:54
|
作者
Hazenberg, BP [1 ]
机构
[1] Albert Schwietzer Ziekenhuis, Lokatie Amstelwijk, Dordrecht, Netherlands
关键词
blood pressure; hypertension; sibutramine; weight loss;
D O I
10.1159/000047310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To compare weight loss efficacy, safety and tolerability of sibutramine and placebo in mildly to moderately obese hypertensive subjects; to assess the effect of weight loss on blood pressure. Design: Randomized, double-blind, parallel-group; 3-week placebo run-in and 12-week treatment phase. Setting: Nine hospital outpatient clinics and general practices in the Netherlands. Participants: 127 men and women, 18-65 years old, with body mass indices (BMI) ranging from 27 to 40 kg/m(2) and stabilized hypertension - mean resting diastolic blood pressure of 90-120 mm Hg - with or without antihypertensive medication. Interventions: Sibutramine 10 mg once daily; placebo. Main outcome measures: Body weight, blood pressure, routine laboratory and clinical safety monitoring. Results: Of 113 evaluable patients, 54 received sibutramine and 59 placebo. Weight reduction was significantly greater with sibutramine from week 2 onwards (last observation carried forward): mean, 4.4 kg with sibutramine and 2.2 kg with placebo (p = 0.002); mean percentage weight reduction, 4.7 and 2.3%, respectively (p < 0.001); mean BMI reduction, 1.6 and 0.8 kg/m(2), respectively (p < 0.01). Reduction in excessive body weight was associated with a reduction in blood pressure in both groups, although the mean reduction in supine diastolic blood pressure was numerically, but not statistically significantly, greater in the placebo group (5.7 mm Hg) compared with the sibutramine group (4.0 mm Hg; p = 0.21). Similar reductions were seen in supine systolic blood pressure. Both treatments were well tolerated. Conclusions: Sibutramine 10 mg once daily is a useful, effective therapy for obesity in the presence of stable hypertension. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [1] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [2] Cardiovascular effects of sibutramine in the treatment of obese adolescents: Results of a randomized, double-blind, placebo-controlled study
    Daniels, Stephen R.
    Long, Barbara
    Crow, Scott
    Styne, Dennis
    Sothern, Melinda
    Vargas-Rodriguez, Ileana
    Harris, Lisa
    Walch, Julia
    Jasinsky, Olga
    Cwik, Kristine
    Hewkin, Ann
    Blakesley, Vicky
    [J]. PEDIATRICS, 2007, 120 (01) : E147 - E157
  • [3] Efficacy of sibutramine for the treatment of binge eating disorder: A randomized multicenter placebo-controlled double-blind study
    Wilfley, Denise E.
    Crow, Scott J.
    Hudson, James I.
    Mitchell, James E.
    Berkowitz, Robert I.
    Blakesley, Vicky
    Walsh, B. Timothy
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (01): : 51 - 58
  • [4] Dyslipidemia in obese adolescents: A double-blind, placebo-controlled study to evaluate treatment with sibutramine
    Berkowitz, R
    Hazan, L
    Jasinsky, O
    Blakesley, V
    [J]. OBESITY RESEARCH, 2005, 13 : A26 - A27
  • [5] SULFASALAZINE IN SPONDYLARTHROPATHY - A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    DOUGADOS, M
    VANDERLINDEN, S
    LEIRISALOREPO, M
    HUITFELDT, B
    BERTOUCH, J
    BROOKS, P
    DIJKMANS, B
    EDMONDS, J
    MAJOR, G
    KVIEN, T
    OLIVIERI, I
    VEYS, E
    ZEIDLER, H
    AMOR, B
    CALIN, A
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S92 - S92
  • [6] Metabolic syndrome in obese adolescents in a double-blind, placebo-controlled study to evaluate treatment with sibutramine
    Daniels, S
    Caprio, S
    Hewkin, A
    Blakesley, V
    [J]. CIRCULATION, 2005, 112 (17) : U908 - U909
  • [7] Four-Year Efficacy and Safety of Sibutramine for Weight Maintenance: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study
    Anderson, James
    Owen, Stanford
    Fajardo, Ben
    Berkson, Joseph
    File, Allan
    Cramer, Sylvia
    Gotthelf, Linda
    [J]. OBESITY, 2008, 16 : S64 - S64
  • [8] Effects of sibutramine on body weight and serum lipids: A double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia
    Dujovne, CA
    Zavoral, JH
    Rowe, E
    Mendel, CM
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (03) : 489 - 497
  • [9] Treatment of obese adolescents with sibutramine: A randomized, double-blind, controlled study
    Godoy-Matos, A
    Carraro, L
    Vieira, A
    Oliveira, J
    Guedes, EP
    Mattos, L
    Rangel, C
    Moreira, RO
    Coutinho, W
    Appolinario, JC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1460 - 1465
  • [10] A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder
    Appolinario, JC
    Bacaltchuk, J
    Sichieri, R
    Claudino, AM
    Godoy-Matos, A
    Morgan, C
    Zanella, MT
    Coutinho, W
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (11) : 1109 - 1116